SWM
BIOC

Spire Wealth Management’s Biocept, Inc. BIOC Stock Holding History

Spire Wealth Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-133
Closed -$4K – 2708
2022
Q2 		$4K Hold
133
– – ﹤0.01% 2235
2022
Q1 		$9K Hold
133
– – ﹤0.01% 2083
2021
Q4 		$14K Hold
133
– – ﹤0.01% 2262
2021
Q3 		$16K Hold
133
– – ﹤0.01% 1947
2021
Q2 		$17K Buy
+133
New +$18K ﹤0.01% 1956

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spire Wealth Management's BIOC Position: Q3 2022 in Review

Spire Wealth Management sold out of Biocept, Inc. (BIOC) in Q3 2022, closing a stake of 133 shares — an estimated $4K sold.

Spire Wealth Management first reported a position in BIOC in Q2 2021 and held it in 5 quarters. The position peaked at $17K in Q2 2021. 26 funds tracked by Wall St. Rank hold BIOC as of Q3 2022.

  • Spire Wealth Management reported no remaining Biocept, Inc. position as of Q3 2022 after selling out during the quarter.
  • Spire Wealth Management sold 133 Biocept, Inc. shares in Q3 2022, an estimated $4K.
  • Spire Wealth Management first reported a position in Biocept, Inc. in Q2 2021 and held it in 5 quarters.
  • Spire Wealth Management's Biocept, Inc. position peaked at $17K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2022.

Based on Spire Wealth Management's 13F filing for Q3 2022, filed 7 Nov 2022.